Capital Performance Advisors LLP

SEC CIK: 0001905663
Latest filing: Aug 14, 2026

SEC filings (opens in a new tab)

MDGL holding history

Madrigal Pharmaceuticals, Inc. in every 13F filed by Capital Performance Advisors LLP, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

MDGL overview All 13F holders of MDGL Full Q2 2026 holdings

Shares (Q2 2025): 0; Sold out in Q2 2025
Value: $0
% of portfolio: 0.0%
Quarters held: 2; Since Q3 2024

Holdings of MDGL by Capital Performance Advisors LLP, by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q2 2025	0	$0	0.0%	−2,422−100.0%	Sold out	Holders
Q1 2025	2,422	$802.2K	0.2%	+2,422	New	Holders
Q4 2024	0	$0	0.0%	−3−100.0%	Sold out	Holders
Q3 2024	3	$637	<0.1%	+3	New	Holders